Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Geriatric-8 (G8) screening tool stratified the efficacy of S-1 plus ramucirumab in elderly patients with advanced/recurrent gastric cancer: A post-hoc analysis of the KSCC1701 trial.
Authors
Qingjiang Hu
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Qingjiang Hu , Koichi Suyama , Kazuma Kobayashi , Hiroo Katsuya , Naoki Izawa , Yoshikazu Uenosono , Tetsuya Kusumoto , Hajime Otsu , Hiroyuki Orita , Hirofumi Kawanaka , Kazunori Shibao , Satoshi Koga , Mototsugu Shimokawa , Akitaka Makiyama , Hiroshi Saeki , Eiji Oki , Hideo Baba , Masaki Mori
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Clinical Trial Registration Number
UMIN000028309
DOI
10.1200/JCO.2022.40.4_suppl.256
Abstract #
256
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
A multicenter phase II study of S-1 plus ramucirumab as first-line treatment in elderly patients with advanced/recurrent gastric cancer (KSCC1701).
First Author: Hiroo Katsuya
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A retrospective analysis of the efficacy and safety of imatinib in elderly patients with advanced gastrointestinal stromal tumor.
First Author: Takahito Awatsu
Poster
2023 ASCO Annual Meeting
Efficacy and safety of lurbinectedin in elderly patients with relapsed SCLC.
First Author: Sophie Cousin
Poster
2023 ASCO Annual Meeting
Subgroup analysis of elderly patients (pts) with diffuse large B-cell lymphoma (DLBCL) in the phase 3 POLARIX study.
First Author: Bei Hu